Waltham

A startup lawyer’s take on winning over a venture capitalist

An article by Mick Bain, originally published in VentureBeat's Deals channel.

2013 IPO Report

Our 2013 IPO Report offers a detailed analysis of, and outlook for, the IPO market. The report features regional breakdowns, a Q&A with former SEC Corp Fin Director Meredith Cross, and a discussion of the use of social media for investor communications under Regulation FD. We review the elements of relief being chosen by emerging growth companies under the JOBS Act; offer practical insight on “test-the-waters” communications and scheduling the first annual meeting of stockholders; summarize IPO disclosure requirements applicable to directors, officers, 5% stockholders and selling stockholders; discuss Form 10 IPOs as an alternative route to going public; and present useful IPO market metrics that are ordinarily unavailable elsewhere.

2013 M&A Report

Our 2013 M&A Report offers a detailed review of, and outlook for, the global M&A market. Other highlights include a discussion of the challenges and benefits of selling your company in a “dual-track” IPO, a comparison of public and private acquisitions, an analysis of issues and opportunities in California M&A deals, and a review of takeover defenses adopted by public companies. It also takes a look at the facts of life in M&A deal litigation, and survey key terms  in sales of VC-backed companies.

2013 Venture Capital Report

Our 2013 Venture Capital Report offers an in-depth analysis of, and outlook for, the US and European venture capital markets. The report features industry and regional breakdowns, an analysis of trends in venture capital financing and VC-backed company M&A deal terms, a look at the federal tax advantages of investments in “qualified small business stock,” and a discussion of JOBS Act benefits for startups that never plan to go public.

2013 Corporate Reports

WilmerHale’s annual IPO, Venture Capital and M&A Reports provide comprehensive statistics and analysis that are hard to find elsewhere.

Selected 2013 Technology Transactions

For more than four decades, we have represented technology clients in venture capital financings, public offerings, and mergers and acquisitions; handled their licensing, outsourcing, services, joint venture, development and distribution transactions throughout the world; protected their innovations through patent prosecution and portfolio development; defended their interests in enterprise‑critical patent litigation; and navigated regulatory issues vital to their success.

Selected 2013 Strategic Alliances, Joint Venture and Licensing Transactions

In 2013, our corporate, licensing, intellectual property and regulatory lawyers handled numerous strategic alliance, joint venture, licensing, collaboration, product development, outsourcing, manufacturing, distribution and similar agreements, including many significant deals that are helping to shape the future of science and technology.

Selected 2013 Life Sciences Transactions

Recognized both globally and nationally as a leading life sciences practice, WilmerHale has four decades of experience representing biotechnology, pharmaceutical and medical device companies at all stages of growth, as well as venture capitalists and investment banks.

WilmerHale Shortlisted for Chambers USA Award for Excellence in IP

Senegal and First Step: Infrastructure to Support Critical Agricultural Supply Chains

The Minister of Economy and Finance, Amadou Kane, acting on behalf of the Government of Senegal signed a Letter of Intent (LOI) yesterday with First Step Economic Opportunity Zone Inc. (First Step) to commence planning and fundraising for the development of a special economic zone in the Casamance region of Senegal.